Rab11a is a small GTP binding protein enriched in the pericentriolar plasma membrane recycling systems. We hypothesized that Rab11a binding proteins exist as downstream effectors of its action. Here we define a family of four Rab11 interacting proteins: Rab11-Family 
Introduction
The Rab GTPase family contains more than 50 different members that are believed to have a regulatory role in the formation, targeting, and/or fusion of transport vesicles (1) . While the precise mechanism of action remains poorly understood, individual Rab proteins localize to distinct intracellular vesicular compartments suggesting that each Rab has a well defined functional role. For example, Rab1 and Rab2 are peri-nuclear in location and function in endoplasmic reticulum (ER) to Golgi translocation (2) . Rab6 is located on the Golgi and is involved in movement of vesicles through the organelle (3) . Rab8 resides in the transGolgi/post-Golgi networks and regulates post-Golgi targeting to the plasma membrane (4) . Rab5 on early endosomes functions in trafficking from the plasma membrane (5) . The sub-apically localized Rab11 family is involved in vesicle recycling, plasma membrane recycling, and transcytosis (6) (7) (8) .
Rab11a was first isolated from bovine brain membranes in 1988 (9) . Since that time, the rat (10), dog (11) , mouse (12) , rabbit (13) and human (14) homologues have been identified. oligonucleotide containing a Sac1 site (5' GAGCCTTTAGATCCACGCCCGAG 3') was utilized to amplify the 542 amino-terminal nucleotides of Rab11-FIP1 from parietal cell cDNA.
Following digestion with Sac1 (New England Biolabs, Beverly, MA), this fragment was ligated (New England Biolabs ligase) to the carboxyl-terminal 1414 nucleotides of Rab11-FIP1 already cloned into the GFP-C2 vector. Rab11-FIP1 was then recloned in pET-30c and pAD-GAL.
Computer gene database search, cloning and yeast two hybrid binary assays of Rab11-FIP1, Rab11-FIP2, Rab11-FIP3 and pp75/Rip11. pAD-GAL4/Rab11-FIP1 mutant constructs were created utilizing PCR amplification and normal cloning techniques. Rab11-FIP2 (KIAA0941), Rab11-FIP3 (KIAA0665) and pp75/Rip11 (KIAA0857) were identified utilizing Rab11-FIP1 to search the human EST database. Rab11-FIP2 (KIAA0941) and Rab11-FIP3 (KIAA0665) were obtained as cDNAs from Dr. Osamu Ohara (Kazusa DNA Research Institute). The Rab11-FIP2 coding sequence was amplified from the KIAA0941 cDNA via PCR using a 5' oligonucleotide with an EcoRI site (GCCGGAATTCAAACAGGACAGGATGATGCT) and 3' oligonucleotide with SalI site (GGCGTCGACAATTGGCTTTATTAACTGTTAGAG), and ligated into pAD-GAL4 digested with EcoRI and SalI. The Rab11-FIP3 coding sequence was amplified from the KIAA0665 cDNA via PCR using a 5' oligonucleotide with an EcoRI site (GCGGAATTCCTCGGGAGCATGGCGTCG) and 3' oligonucleotide with XbaI site (CGCGTCTAGAGCTGGACCTTCCTGCCTCTACTTG) and ligated into pAD-GAL4 and EGFP-C2 digested with EcoRI and XbaI. pAD-GAL4/pp75/Rip11 was prepared as previously described (26) . minutes. The yeast cells were pelleted at 1000g for 30 seconds, the supernatant was removed, the cells were resuspended in 100 µl sterile water, and then the cells were plated onto a tryptophan and leucine deficient media. The plate was incubated at 30°C for 3 days and the colonies were lifted with a 70 mm filter paper disc. The discs were then processed for detection of β-galactosidase activity as detailed above. Observation of a blue color within 3 hours was considered a positive result.
Antibody and recombinant protein production. Rab11-FIP1(263-651) was cloned into and recombinant His-tagged-Rab11-FIP1(263-651) was expressed and purified as previously described (16) . Mouse monoclonal Rab11-FIP1 antibody was produced against recombinant Rab11-FIP1(263-651) at the University of Georgia Monoclonal Antibody Facility. Polyclonal Rab11-FIP2 antibody was produced in goat by Strategic Biosolutions (Ramona, California) against peptide (NRQDYFDYESTN) spanning amino acids 395 to 406 of Rab11-FIP2 conjugated to Keyhole Limpet Hemocyanin (KLH). Rabbit polyclonal pp75 was produced as described previously (26) .
Full length Rab11-FIP1, Rab11-FIP1(1-615), Rab11-FIP2, Rab11-FIP2(1-465), and Rab11-FIP3 sequences were cloned into pET-30a and recombinant expression protein was purified as previously described. (16 Parietal cell tubulovesicle preparation and western blot analysis. Enriched parietal cell tubulovesicle preparation was conducted as previously described (28) . 20 µg protein from each fraction were electrophoresed on 10% SDS-polyacrylamide gels and transferred to Immobilon-P (Millipore, Bedford, MA). Membranes were blocked for 1 hour in blocking buffer (TBS with 5% nonfat milk and 0.05% Tween-20). Membranes were then probed with the appropriate primary antibody in 2 ml of antibody incubation buffer (TBS with 2.5% nonfat milk and 0.05% Tween-20) for 2 hours. Antibody dilutions were as follows: Rab11-FIP1 was used at 1:10000;
Rab11-FIP2 was used at 1:100; Rab11a (8H10-(16)) was used at 1:50; H + K + -ATPase was used at 1:50,000. Membranes were washed 3 times for 10 minutes each with blocking buffer.
Membranes were then probed with appropriate HRP-conjugated secondary antibodies (Jackson ImmunoResearch) in 2 ml antibody incubation buffer. All HRP-conjugated secondary antibodies were used at 1:3000. Membranes were washed 3 times for 10 minutes in TBS and developed with Super Signal Chemilumenescent Substrate (Peirce) for one minute followed by exposure to film (Kodak, Biomax-ML).
Cell culture and immunofluorescence microscopy. HeLa cells were grown to confluence on glass coverslips. MDCK cells were grown to confluence on Transwell filters. Primary rabbit parietal cells were isolated and maintained in culture for 2 days following harvesting on glass coverslips coated with Matrigel (Becton-Dickenson) as previously described (30) (31) .
Nocodazole and taxol treatment of MDCK cells was performed as previously described (7, 29) .
Prior to fixing, all cells were washed 2 times with PBS (150 mM NaCl and 150 mM sodium phosphate pH 7.4). All cells were fixed for 30 minutes at 4°C in 4% paraformaldehyde and washed 3 times with PBS prior to storage at 4°C in PBS.
To stimulate parietal cells, media was changed 24 hours after plating cells. Cells were then pretreated for 5 minutes with 10 µM omeprazole prior to the addition of 100 µM histamine for 30 minutes. Cells were then washed 3 times for 10 minutes with PBS and fixed as above.
Transient transfection of GFP-Rab11-FIP3 into HeLa cells was conducted as described previously (24 Coverslips or filters were mounted onto slides using Prolong Antifade (Molecular Probes, Eugene, OR).
HeLa cells were observed utilizing a Zeiss Axiphot equipped with a SPOT digital imaging system. MDCK cells were imaged utilizing a Molecular Dynamics confocal microscope as previously described (6) . Parietal cells were imaged in confocal microscopy using single 0.3 µm optical sections.
Results:
Dominant active Rab11a identifies Rab11-FIP1 from a rabbit parietal cell cDNA library. To identify proteins that interact with Rab11a, a yeast two-hybrid screen of a rabbit parietal cell library was performed with dominant active Rab11a (Rab11aS20V). Two clones for an identical cDNA sequence were found to activate histidine production and to produce β-galactosidase. Figure 3A ). Other than the helix, these three proteins demonstrated no significant identity with Rab11-FIP1.
KIAA0941 was first published as one of 100 cDNAs isolated from human brain which code for large proteins (33) . By utilizing the PROSITE domain search engine, KIAA0941 was found to contain a putative amino terminal C2-domain which was similar to the C2-domain present in synaptotagmin ( Figure 3B ). The KIAA0941 sequence is located on chromosome 10 with 5 exons and only 15.6 percent overall identity to Rab11-FIP1.
KIAA0857 was initially published by T. Nagase and colleagues (34) (27) did not compete with the recombinant Rab11-FIP1, Rab11-FIP2 or Rab11-FIP3 for the labeled Rab11a ( Figure 5 ).
Mouse monoclonal Rab11-FIP1 antibody and goat polyclonal Rab11-FIP2 antibody. To assess endogenous expression of the Rab11-FIP proteins, we developed antibodies against Rab11-FIP1 and Rab11-FIP2. A mouse monoclonal antibody was raised against recombinant Rab11-FIP1 and a goat polyclonal antibody was raised against a Rab11-FIP2 specific peptide.
The western blot in Figure 6A indicated that the monoclonal Rab11-FIP1 antibody is specific.
Incubation of the antibody with recombinant Rab11-FIP1 for 1 hour blocked in a concentration dependent manner the antibody binding to an 89 kDa band in 100,000g microsomes isolated from gastric mucosa. Similar results were found with the polyclonal goat anti-Rab11-FIP2
antibody. The Rab11-FIP2 peptide used to immunize the goat blocked in a concentration dependent manner antibody binding to a 68 kDa band in the same microsomal fraction in a concentration dependent manner ( Figure 6B ). Rab11-FIP1 antibodies did not recognize Rab11- 
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Figure 1:
1 CACTCGTTTGCTGGCTTTGATGAGGAGGCTGGGAAGGCCATGACCCTGCCGTCCTACCGACCGCAAGTCACTGGGGATGCCCAGGAAGACAGGGCTCTGGCC AGC ATG GAG GCT GCA AGA GAA ACC CAG GAG GGC AAG AAA CAG GAG AGC AAG AAG GCC TCT TTG CTG TCT CTG GTG 178 T  GGG GAT TCT GCG GCT GCT GCC TCC GCT CAG GGC CAC GCC CTG AAC CCC TTT GAA GAT GTG CAG ATT ACA GAA 322  49 G  D  S  A  A  A  A  S  A  Q  G  H  A  L  N  P  F  E  D  V  Q  I  T  E  GCC GAA GCC GAC CCA GAG TCC CAG GCT GGA CCA AAG CCG CCC GTT CCC ACG CCG AGG GCG CTG CAG ACC AAG 394  73 A  E  A  D  P  E  S  Q  A  G  P  K  P  P  V  P  T  P  R  A  L  Q  T  K  GCC GTC AAG CCC CGA GTG GAC GTG TCT CCA GAG GCG CCA CCC AAA GCC AGG CCT TCT TCT CCC CCC AGC TCG 466  97 A  V  K  P  R  V  D  V  S  P  E  A  P  P  K  A  R  P  S  S  P  P  S  S  CCC CTA GCC TCT CCC CGG GCC CCT CCC GAA GCA GAG CCC TCC TCC ATC TCT TCC TCC TCC TCC TTG TGG TCT 538 
